| Literature DB >> 15780632 |
Sheng-Li Cao1, Yu-Ping Feng, Yu-Yang Jiang, Shi-Ying Liu, Guo-Yu Ding, Run-Tao Li.
Abstract
A series of 4(3H)-quinazolinone derivatives with dithiocarbamate side chains were synthesized and tested for their in vitro antitumor activity against human myelogenous leukemia K562 cells. Among them, (3,4-dihydro-2-methyl-4-oxoquinazolin-6-yl)methyl 4-(4-fluorophenyl)piperazine-1-carbodithioate 8q exhibited significant inhibitory activity against K562 cells with IC(50) value of 0.5 microM.Entities:
Mesh:
Substances:
Year: 2005 PMID: 15780632 DOI: 10.1016/j.bmcl.2005.01.083
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823